Abiopharma

MLTX Investor Deadline Alert: MoonLake (MLTX) Class Action Lawsuit - Hagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms

SPIE announces the success of its SHARE FOR YOU 2025 employee shareholding plan and its intention to implement an anti-dilutive share buyback program

Updated data for Lillys Inluriyo™ (imlunestrant) reinforce efficacy results as monotherapy and in combination with Verzenio® (abemaciclib) in ER+, HER2- advanced breast cancer

SPIE annonce le succès de son programme d’actionnariat salarié SHARE FOR YOU 2025 et son intention de mettre en œuvre un programme de rachat d’actions anti-dilutif

Aspo Oyj: Omien osakkeiden hankinta 12.12.2025

Aspo Plc: Share repurchase 12.12.2025

CLIQ Digital AG: CLIQ Digital AG plans transfer to the Basic Board of the open market of the Frankfurt Stock Exchange

CLIQ Digital AG: Cliq Digital AG plant Wechsel in das Basic Board des Freiverkehrs an der Frankfurter Wertpapierbörse

Cadrenals Quiet Expansion Play Is Starting to Get Loud

Mineralys Therapeutics’ Phase 3 Launch-HTN Trial of Lorundrostat Recognized in Inaugural Journal of the American Medical Association (JAMA)“Research of the Year” Roundup